✦ LIBER ✦

Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

✍ Scribed by P. W. COLLINS; V. S. BLANCHETTE; K. FISCHER; S. BJÖRKMAN; M. OH; S. FRITSCH; P. SCHROTH; G. SPOTTS; J. ASTERMARK; B. EWENSTEIN; ON BEHALF OF THE RAHF-PFM STUDY GROUP

Book ID: 109152826
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 202 KB
Volume: 7
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2008.03270.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factor VIII requirement to maintain a ta

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

✍ P. W. COLLINS; S. BJÖRKMAN; K. FISCHER; V. BLANCHETTE; M. OH; P. SCHROTH; S. FRI 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB